Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Volitionrx (VNRX) Return on Capital Employed (2019 - 2025)

Historic Return on Capital Employed for Volitionrx (VNRX) over the last 8 years, with Q3 2025 value amounting to 5.9%.

  • Volitionrx's Return on Capital Employed rose 41800.0% to 5.9% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.9%, marking a year-over-year increase of 41800.0%. This contributed to the annual value of 2.48% for FY2024, which is 600.0% up from last year.
  • Latest data reveals that Volitionrx reported Return on Capital Employed of 5.9% as of Q3 2025, which was up 41800.0% from 37.34% recorded in Q2 2025.
  • In the past 5 years, Volitionrx's Return on Capital Employed registered a high of 37.34% during Q2 2025, and its lowest value of 35.59% during Q1 2023.
  • In the last 5 years, Volitionrx's Return on Capital Employed had a median value of 2.56% in 2023 and averaged 3.95%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first skyrocketed by 401200bps in 2024, then crashed by -397200bps in 2025.
  • Over the past 5 years, Volitionrx's Return on Capital Employed (Quarter) stood at 1.27% in 2021, then tumbled by -627bps to 9.26% in 2022, then skyrocketed by 72bps to 2.56% in 2023, then tumbled by -225bps to 8.32% in 2024, then soared by 171bps to 5.9% in 2025.
  • Its Return on Capital Employed was 5.9% in Q3 2025, compared to 37.34% in Q2 2025 and 35.19% in Q1 2025.